With the rapid increase in the number of interventional clinical trials in Duchenne muscular dystrophy (DMD) over the past few years, the need for a frank and honest discussion between those designing and using outcome measures has never been greater. In January 2017 clinicians, physiotherapists, imaging experts and patient advocacy group representatives came together for a two day workshop at The Foundry in London, UK, for a critical review of the different clinical outcome measures used to date in natural history studies and interventional trials for DMD.

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...